PharmTech Talk

Nov 07, 2017
By Pharmaceutical Technology Editors
While most pharma companies are in partial production using generators, few are operating at 100% capacity.
Nov 07, 2017
By Pharmaceutical Technology Editors
The debate continues over biosimilar naming, interchangeability, and patent protection, as well as lingering concerns in the medical community about the safety of switching patients to new therapies.
Oct 05, 2017
FDA and manufacturers strive to prevent drug shortages from Hurricane Maria.
Sep 25, 2017
Biopharmaceutical companies developing new competitive biotech therapies have pressed hard for clarity on the testing and data required by FDA to gain market approval of biosimilars that can be filled by a pharmacist without prescriber preapproval.
Aug 28, 2017
High-priority issues requiring immediate attention leave little time for Congress to consider drug access proposals that have limited bipartisan support.
Aug 10, 2017
PTSM: Pharmaceutical Technology Sourcing and Management
Efforts to establish an international system for identifying and tracing drugs through the global supply chain are moving forward.
Aug 08, 2017
The Senate voted 94–1 to approve legislation reauthorizing user fees and a series of program changes; President Trump signs legislation.
Jul 28, 2017
Manufacturers are seeking greater oversight of how providers reimburse for and dispense covered drugs.
Jul 12, 2017
A recent paper coauthored by FDA’s Lawrence Yu and Michael Kopcha describes how the industry might modernize drug manufacturing.
Jul 05, 2017
By Pharmaceutical Technology Editors
A Supreme Court decision and improvements in analytical processes may speed the biosimilar approval process.
lorem ipsum